Sunlight Omnisense™ 7000S--Wrist Watch
 |
Consider this: 28 million Americans face the threat of osteoporosis and its 1.5 million related bone fractures--about half your female patients. You know one key to beating it lies in spotting trends through early detection and frequent follow-up. Cost prohibitive for patient and physician alike--until now. Enter the Sunlight Omnisense™ 7000S bone sonometer--so accurate and economical, it's poised to become the new standard in bone strength assessment. Sunlight's patented Omnipath™ technology takes the Omnisense 7000S beyond the one-time snapshot. Its low cost allows you to offer and perform in-office measurements more frequently with just a one-minute pass over the wrist--developing a profile that flags osteoporotic development early on. Finally, a way to meet the burgeoning demand for a complete bone assessment solution cost-effectively, with no compromise in accuracy or precision. It's about time. Diagnose and monitor osteoporosis
|
At Last: Diagnose and Monitor Osteoporosis at the Point of Care
Sunlight's Omnisense™7000S bone sonometer is an office-based solution so accurate, it has an FDA approved claim for monitoring bone changes over time. The technician simply scans the patient's wrist and, in minutes, generates a comprehensive picture of fracture risk.
The Omnisense 7000S uses a patented axial transmission form of quantitative ultrasound we call Omnipath™. Instead of relying on x-rays, Omnipath measures the velocity of ultrasonic waves (speed of sound) that propagate axially along the distal 1/3 radius. The resulting output considers multiple bone strength properties such as bone mineral density (BMD), elasticity, cortical thickness, and micro-architecture--without soft-tissue-related inaccuracies so typical with other testing devices.
The system uses World Health Organization (WHO) criteria in assessing fracture risk and user- friendly software allows you to store comprehensive patient information. This scalable platform includes a record management database and patient scheduling system.
Sample of Common lCD-9 Codes for Bone Densitometry*
Reimbursement Information
Bone Mass Measurement Rule : rule for coverage and payment of bone mass measurements as published in The Federal Register Volume 63 November 121/Wednesday, June 24, 1998, states that bone strength assessment with an FDA-approved bone sonometer is reimbursable.
Reimbursement : Medicare reimbursement ultrasound testing is covered under CPT code 76977. HCFA/Medicare 2001 national average is approximately $58 per study. Most insurance companies reimburse for Ultrasonometry studies.
Conditions for Coverage : A woman determined by the physician to be estrogen deficient and at clinical risk for osteoporosis, based on medical history and other findings.
An individual with vertebral abnormalities as demonstrated by an x-ray indicating osteoporosis, osteopenia, or
vertebral fracture.
An individual receiving or expecting to receive glucocorticoid steroid therapy.
An individual with primary hyperparathyroidism.
An individual being monitored to assess response to or efficacy of an FDA-approved osteoporosis drug therapy.
Repetitive Testing : Medicare may cover repetitive testing after 23 months of last test, more frequently if medically necessary.
*Medicare reimbursement rates vary by region. Please check your local carrier for exact amount and guidelines for filing of claims.
